Cerebellar amyloid-β plaques: Disturbed cortical circuitry in aβPP/PS1 transgenic mice as a model of familial Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 31, Issue 2, 2012, Pages 285-300

  Lomoio, Selene ^a,b   López González, Irene ^b   Aso, Ester ^b   Carmona, Margarita ^b   Torrejón Escribano, Benjamín ^c   Scherini, Elda ^a   Ferrer, Isidro ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

A PP PS1 transgenic mice; cerebellum; familiar Alzheimer disease; parallel fibers; Purkinje cell

Indexed keywords

AMYLOID BETA PROTEIN; CALRETININ; PRESENILIN 2; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEGENERATION; CEREBELLUM; CONTROLLED STUDY; DENDRITIC SPINE; FAMILIAL ALZHEIMER DISEASE; GENE MUTATION; GRANULE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOTOR DYSFUNCTION; MOUSE; NEURITE; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; TRANSGENIC MOUSE;

EID: 84865611781     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-112198     Document Type: Article

References (44)

1. Duyckaerts C, Dickson DW (2003) Neuropathology of Alzheimer's disease. In: Neurodegeneration: The molecular pathology of dementia and movement disorders. DicksonDW, ed., ISN Neuropath Press, Basel, pp. 47-65.
2. Lowe J, Mirra SS, Hyman B, Dickson DW (2008) Ageing and dementia. In: Greenfield's Neuropathology, vol 1. Love S, Louis DN, Ellison DW, eds., Hodder Arnold, London, pp. 1031-1152.
3. Bettens K, Sleegers K, Van Broeckhoven C (2010) Current status of Alzheimer disease molecular genetics: From past, to present, to future. Hum Mol Genet 19(R1), R4-R11.
4. DicksonDW,Wertkin A, Mattiace LA, Fier E, KressY, Davies P, Yen SH (1990) Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer's disease. Acta Neuropathol 79, 486-493. (Pubitemid 20095407)
5. Mavroudis IA, Fotiou DF, Adipepe LF, Manani MG, Njau SD, Psaroulis D, Costa VG, Baloyannis SJ (2010) Morphological changes of the human Purkinje cells and deposition of neuritic plaques and neurofibrillary tangles on the cerebellar cortex of Alzheimer's disease. Am J Alzheimers Dis Other Demen 25, 585-591.
6. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791-1800. (Pubitemid 34663580)
7. Wegiel J, Wisniewski HM, Dziewiatkowski J, Badmajew E, Tarnawski M, Reisberg B, Mlodzik B, De Leon MJ, Miller DC (1999) Cerebellar atrophy in Alzheimer's disease-clinicopathological correlations. Brain Res 818, 41-50. (Pubitemid 29227282)
8. FukutaniY, Cairns NJ, RossorMN,LantosPL(1996) Purkinje cell loss and astrocytosis in the cerebellum in familial and sporadic Alzheimer's disease. Neurosci Lett 214, 33-36. (Pubitemid 26273982)
9. Giaccone G, Morbin M, Moda F, Botta M, Mazzoleni G, Uggetti A, Catania M, Moro ML, Redaelli V, Spagnolki A, Rossi RS, Salmona M, DiFede G, Tagliavini F (2010) Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features. Acta Neuropathol 120, 803-812.
10. Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, Yamaguchi H, Ruiz A, Martinez A, Madrigal L, Hincapie L, Arango JC, Anthony DC, Koo EH, Goate AM, Selkoe DJ, Arango JC (1996) The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat Med 2, 1146-1150. (Pubitemid 26338637)
11. Lopera F, Ardilla A, Martinez A, Madrigal L, Arango-Viana JC, Lemere CA, Arango-Lasprilla JC, Hincapie L, Arcos-Burgos M, Ossa JE, Behrens IM, Norton J, Lendon C, Goate AM, Ruiz-Linares A, Rosselli M, Kosik KS (1997) Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 277, 793-799. (Pubitemid 27111314)
12. Sepulveda-Falla D, Matschke J, Bernreuther C, Hagel C, Puig B, Villegas A, Garcia G, Zea J, Gomez-Mancilla B, Ferrer I, Lopera F, Glatzel M (2011) Deposition of hyperphosphorylated tau in cerebellum of PS1E280A Alzheimer's disease. Brain Pathol 21, 452-463.
13. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH,Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG, Sisodia SS (1996) Familial Alzheimer's disease linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1011.
14. Aso E, Lomoio S, Ĺopez-Gonźalez I, Joda L, Carmona M, Ferńandez-Yag̈ue N, Moreno J, Juv́e S, Pujol A, Pamplona R, Portero-Otin M, Mart́ n V, D́ az M, Ferrer I (2011) Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer disease. Brain Pathol, doi: 10.1111/j.1750-3639.2011.00560.x.
15. Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, Canton T, Jedidi I, Gohin M, Wirths O, Bayer TA, Langui D, Duyckaerts C, Tremp G, Pradier L (2003) Time sequence of maturation of dystrophic neurites associated with Abeta deposits in A-P/PS1 transgenic mice. Exp Neurol 184, 247-263. (Pubitemid 37444035)
16. Savonenko A, Xu GM, Melnikova T,Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR (2005) Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: Relationships to-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis 18, 602-617.
17. Pera M, Alcolea D, Śanchez-Valle R, Guardia-Laguarta C, Badiola N, Súarez-Calvet M, Llad́o A, Barrera-Ocampo AA, Sepulveda-Falla D, Blesa R, Molinuevo JL, Clariḿon J, Ferrer I, Gelpi E, Lléo A (2012) Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease, submitted.
18. Ferrer I, Serrano T, Rivera R, Oliv́e M, Źujar MJ, Graus F (1993) Radiosensitive populations and recovery in X-ray-induced apoptosis in the developing cerebellum. Acta Neuropathol 86, 491-500. (Pubitemid 23322250)
19. Manders EM, Stap J, Brakenhoff GJ, van Driel R, Aten JA (1992) Dynamics of three dimensional replication patterns during the S-phase, analyzed by double-labeling of DNA and confocal microscopy. J Cell Sci 103, 857-862. (Pubitemid 23023255)
20. Abad MA, Enguita M, DeGregorio-Rocasolano N, Ferrer I, Trullas R (2006) Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain. J Neurosci 26, 12735-12747. (Pubitemid 44904569)
21. Enguita M, DeGregorio-Rocasolano N, Abad A, Trullas R (2005) Glycogen synthase kinase 3 activity mediates neuronal pentraxin 1 expression and cell death induced by potassium deprivation in cerebellar granule cells. Mol Pharmacol 67, 1237-1246. (Pubitemid 40410424)
22. Carpenter MB (1991) Core text of neuroanatomy 4th Ed. Williams andWilkins, Baltimore, Buenos Aires, Hong Kong, London, Munich, Philadelphia, Sydney, Tokyo.
23. Llińas R, Hillamn DE (1969) Physiological and morphological organization of the cerebellar circuits in various vertebrates. In: Neurobiology of cerebellar evolution and development. Llinas R, ed., AMA-ERF Institute for Biomedical Research, Chicago, pp. 43-73.
24. Palay SL, Chan-Palay V (1974) Cerebellar Cortex. Cytology and Organization. Springer-Verlag, Berlin, Heidelberg, New York.
25. Raḿon y Cajal S (1899) Textura del Sistema Nervioso del Hombre y de los Vertebrados. Imprenta y Libreŕa de Nicoĺas Moya, Madrid. Re-edited by Instituto de Neurociencias, Universidad de Alicante, 1992.
26. Hioki H, Fujiyama F, Taki K, Tomioka R, Furuta T, Tamamaki N, Kaneko T (2003) Differential distribution of vesicular glutamate transporters in the rat cerebellar cortex. Neuroscience 117, 1-6. (Pubitemid 36246497)
27. Bastianelli E (2003) Distribution of calcium-binding proteins in the cerebellum. Cerebellum 2, 242-262. (Pubitemid 38280282)
28. Celio MR (1990) Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35, 375-475. (Pubitemid 20176750)
29. Deshpande A, Mina E, Glabe C, Busciglio J (2006) Different conformation of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26, 6011-6018. (Pubitemid 44318367)
30. Glabe CG, KayedR(2006) Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66, S74-S78. (Pubitemid 43739989)
31. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46, 860-466.
32. Ono K, Yamada M (2011) Low-n oligomers as therapeutic targets of Alzheimer's disease. J Neurochem 117, 19-28.
33. Shankar GM, Li S, Metha TH, Garcia-Muñoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14, 837-842.
34. van Helmond Z, Miners JS, Kehoe PG, Love S (2010) OligomericA-in Alzheimer's disease: Relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy. Brain Pathol 20, 468-480.
35. Nicoll JA, Barton E, Boche D, Neal JW, Ferrer I, Thompson P, Vlachouli C, Wilkinson D, Bayer A, Games D, Seubert P, Schenk D, Holmes C (2006) Abeta species removal after abeta42 immunization. J Neuropathol Exp Neurol 65, 1040-1048. (Pubitemid 44684661)
36. Xiong H, Callaghan D, Wodzinska J, Xu J, Premyslova M, LiuQY, Connelly J, ZhangW(2011) Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease. Neurosci Bull 27, 221-232.
37. Aho L, Pikkarainen M, Hiltunen M, Leinonen V, Alafuzoff I (2010) Immunohistochemical visualization of amyloid-beta protein precursor and amyloid-beta in extra-and intracellular compartments in the human brain. J Alzheimers Dis 20, 1015-1028.
38. Hashimoto M, Bogdanovic N, Volkmann I, Aoki M, Winblad B, Tjernberg LO (2010) Analysis of microdissected human neurons by a sensitive ELISA reveals a correlation between elevated intracellular concentrations of A-42 and Alzheimer's disease neuropathology. Acta Neuropathol 119, 543-554.
39. Brooks WS, Kwok JB, Kril JJ, Broe GA, Blumbergs PC, Tannenberg AE, Lamont PJ, Hedges P, Schofiled PR (2003) Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques:Two pedigrees with PS-1 exon deletions. Brain 126, 783-791. (Pubitemid 36372979)
40. Houlden H, Baker M, McGowan E, Lewis P, Hutton M, Crook R,WoodNW, Kumar-Singh S, Geddes J, Swash M, Scaravilli F, Holton JL, Lashley T, Tomita T, Hashimoto T,Verkkoniemi A, Kalimo H, Somer M, Paetau A, Martin JJ, van Broeckhoven C, Golde T, Hardy J, Halktia M, Revesz T (2000) Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol 48, 806-808.
41. Martikainen P, Pikkarainen M, P̈ontynen K, Hiltunen M, Lehtovirta M, Tuisku S, Soininen H, Alafauzoff I (2010) Brain pathology in three subjects from the same pedigree with presenilin-1 (PSEN1) P264L mutation. Neuropathol Appl Neurobiol 36, 41-54.
42. Takao M, Ghetti B, Hayakawa I, Ikeda E, Fukuuchi Y, Miravalle L, Piccardo P, Murrell JR, Glazier BS, Koto A (2002) A novel mutation (G217D) in the presenilin 1 gene (PSEN1) in a Japanese family: Presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum. Acta Neuropathol 104, 155-170. (Pubitemid 36075374)
43. Verkkoniemi A, Somer M, Rinne JO, Myllykangas L, Crook R, Hardy J, Viitanen M, Kalimo H, Haltia M (2000) Variant Alzheimer's disease with spastic paraparesis: Clinical characterisation. Neurology 54, 1103-1109. (Pubitemid 30151853)
44. Wirths O, Weis J, Szczygielski J, Multhaup G, Bayer TA (2006) Axonopathy in an A-P/PS1 transgenic mouse model of Alzheimer's disease. Acta Neuropathol 111, 312-319.